ОБ ЭТОМ ЭПИЗОДЕ

английский
США

РАСШИФРОВКА 🔗

ПОИСК ПРОШЛЫХ ЭПИЗОДОВ

Искать прошлые эпизоды Transcribed.

ДРУГИЕ ЭПИЗОДЫ В ЭТОМ ПОДКАсте

From dreaming of becoming a pilot to engineering proteins with light, Prof. Dr. Dominik Niopek sits at the cutting edge of programmable biology — building tools that let scientists control gene editing with a laser beam. In this episode, he walks us through how CRISPR went from a test tube experime…
After four decades at the intersection of science, industry, and strategy — from the DKFZ bench to 14 years in pharma R&D to two decades writing the EY Biotech Report — Dr. Siegfried Bialojan has watched German biotech ask the same question for 25 years: why doesn't the money show up? In this e…
Welcome back to Transcribed, the podcast where we unpack the minds building the future of biotech. Today's guest, Professor Dr. Kerstin Goepfrich, is asking one of the most fundamental questions in all of science: what is life, and can we build it from scratch? As a full professor at Heidelberg Uni…
As managing director of BioRN, Dr. Julia Schaft sits at the center of one of Europe's most powerful biotech ecosystems — connecting world-class research institutions, startups, and 9 of the top 20 global pharma companies within the Heidelberg region. In this episode, she unpacks why Europe keeps lo…
From starting and selling companies across three continents to backing the next wave of European biotech, Dr. Andreas Schmidt now sits at the intersection of founder, operator, and investor. In this episode, he explains why "venture capital is the most expensive money" and when founders s…
Отказ от ответственности: Подкаст и иллюстрации, встроенные в эту страницу, взяты из Transcribed, который является собственностью его владельца и не связан или не одобрен Listen Notes, Inc.